Dexketoprofen-induced antinociception in animal models of acute pain: Synergy with morphine and paracetamol

Neuropharmacology

Volumn 52, Issue 2, 2007, Pages 291-296

  Miranda, Hugo F ^a   Puig, Margarita M ^b   Dursteler, Christian ^b   Prieto, Juan Carlos ^a,c   Pinardi, Gianni ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Antinociception; Dexketoprofen; Formalin assay; Isobologram; Ketoprofen; Morphine; Paracetamol; Synergy; Tail flick test; Writhing test

Indexed keywords

ACETIC ACID; DEXKETOPROFEN; FORMALDEHYDE; KETOPROFEN; MORPHINE; PARACETAMOL; SODIUM CHLORIDE;

ACUTE PHASIC PAIN; ACUTE TONIC PAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; INFLAMMATION; INFLAMMATORY PAIN; ISOBOLOGRAM; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TAIL FLICK TEST; WRITHING TEST;

ACETAMINOPHEN; ACUTE DISEASE; ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; KETOPROFEN; MALE; MICE; MORPHINE; PAIN; PAIN MEASUREMENT;

EID: 33846438213     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.07.025     Document Type: Article

References (34)

1. Bodnar R.J., and Klein G.E. Endogenous opiates and behavior: 2004. Peptides 26 (2005) 2629-2711
2. Bonnefont J., Alloui A., Chapuy E., Clottes E., and Eschalier A. Orally administered paracetamol does not act locally in the rat formalin test. Anesthesiology 99 (2003) 976-981
3. Carabaza A., Cabre F., Rotllan E., Gomez M., Gutierrez M., Garcia M.L., and Mauleon D. Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs. J. Clin. Pharmacol. 36 (1996) 505-512
4. Díaz-Reval M.I., Ventura-Martinez R., Deciga-Campos M., Terron J.A., Cabre F., and Lopez-Muñoz F.J. Evidence for a central mechanism of action of S(+)-ketoprofen. Eur. J. Pharmacol. 483 (2004) 241-248
5. Djellas Y., Antonakis K., and Le Breton G.C. Shifts in the affinity distribution of one class of seven-transmembrane receptors by activation of a separate class of seven-transmembrane receptors. Biochem. Pharmacol. 59 (2002) 1521-1529
6. Fürst S. Transmitters involved in antinociception in the spinal cord. Brain Res. Bull. 48 (1999) 129-141
7. Gaitan G., and Herrero J.F. Subanalgesic doses of dexketoprofen trometamol enhance the potency and duration of fentanyl antinociception. Br. J. Pharmacol. 135 (2002) 393-398
8. Gaitan G., and Herrero J.F. Subanalgesic doses of dexketoprofen and HCT-2037 (nitrodexketoprofen) enhance fentanyl antinociception in monoarthritic rats. Pharmacol. Biochem. Behav. 80 (2005) 327-332
9. Graham G.G., and Scott K.F. Mechanism of action of paracetamol. Am. J. Ther. 12 (2005) 46-55
10. Iohom G., Walsh M., Higgins G., and Shorten G. Effect of perioperative administration of dexketoprofen and opioid requirements and inflammatory response following elective hip arthroplasty. Br. J. Anaesth. 88 (2002) 520-526
11. Jamaly F., Lovlin R., and Aberg G. Bi-directional chiral inversion of ketoprofen in CD-1 mice. Chirality 9 (1997) 29-31
12. Laudanno O.M., Piombo G., Cesolaria J.A., Godoy A., Rocaspana A., and Aramberry L. Dexketoprofene, selective COX-1 inhibitor NSAID, without gastrointestinal injury in rats. Acta Gastroenterol. Latinoam. 32 (2002) 17-20
13. Le Bars D., Gozariu M., and Cadden S.W. Animals models of nociception. Pharmacol. Rev. 53 (2001) 597-652
14. Mauleon D., Artigas R., Garcia M.L., and Carganico G. Preclinical and clinical development of dexketoprofen. Drugs 52 (1996) 24-45
15. Mazario J., Roza C., and Herrero J.F. The NSAID dexketoprofen trometamol is a potent as μ-opioids in the depression of wind-up and spinal cord nociceptive reflexes in normal rats. Brain Res. 816 (1999) 512-517
16. Mazario J., Gaitan G., and Herrero J.F. Cyclooxygenase-1 versus cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes. Neuropharmacology 40 (2001) 937-945
17. McGurk M., Robinson P., Rajayogeswaran V., De Luca M., Casini A., Artigas R., Muñoz G., and Mauleon D. Clinical comparison of dexketoprofen trometamol, ketoprofen, and placebo in postoperative dental pain. J. Clin. Pharmacol. 38 (1998) 46-54
18. Miranda H.F., Sierralta F., and Pinardi G. An isobolographic analysis of the adrenergic modulation of diclofenac antinociception. Anesth. Analg. 93 (2001) 430-435
19. Miranda H.F., Sierralta F., and Pinardi G. Neostigmine interactions with non steroidal anti-inflammatory drugs. Br. J. Pharmacol. 135 (2002) 1591-1597
20. Miranda H.F., Lemus I., and Pinardi G. Effect of the inhibition of serotonin biosynthesis on the antinociception induced by nonsteroidal anti-inflammatory drugs. Brain Res. Bull. 61 (2003) 417-425
21. Miranda H.F., Silva E., and Pinardi G. Synergy between the antinociceptive effects of morphine and NSAIDs. Can. J. Physiol. Pharmacol. 82 (2004) 331-338
22. Miranda H.F., Puig M.M., Prieto J.C., and Pinardi G. Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain. Pain 121 (2006) 22-28
23. Ossipov M.H., Jerussi T.P., Ren K., Sun H., and Porreca F. Differential effects of spinal (R)-ketoprofen and (S)-ketoprofen against signs of neuropathic pain and tonic nociception: evidence for a novel mechanism of action of (R)-ketoprofen against tactile allodynia. Pain 87 (2000) 193-199
24. Pickering G., Loriot M.A., Libert F., Eschalier A., Beaune P., and Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin. Pharmacol. Ther. 79 (2006) 371-378
25. Pinardi G., Sierralta F., and Miranda H.F. Adrenergic mechanism in antinociceptive effects of non steroidal anti-inflammatory drugs in acute thermal nociception in mice. Inflamm. Res. 51 (2002) 219-222
26. Pinardi G., Sierralta F., and Miranda H.F. Atropine reverses the antinociception of nonsteroidal anti-inflammatory drugs in the tail-flick test of the mice. Pharmacol. Biochem. Behav. 74 (2003) 603-608
27. Raffa R.B., Clark-Vetri R., Tallarida R.J., and Wertheimer A.I. Combination strategies for pain management. Expert Opin. Pharmacother. 4 (2003) 1697-1708
28. Rosland J.H., Tjolsen A., Maehle B., and Hole K. The formalin test in mice, effect of formalin concentration. Pain 42 (1990) 235-242
29. Rudy A.C., Liu Y., Brater C., and Hall S.D. Stereoselectivity pharmacokinetics and inversion of (R)-ketoprofen in healthy volunteers. J. Clin. Pharmacol. 38 Suppl. 2 (1998) 3S-10S
30. Tallarida R.J., and Murray R.B. Manual of Pharmacological Calculations (1987), Springer-Verlag, New York p. 19
31. Tallarida R.J. Drug synergism: its detection and applications. J. Pharmacol. Exp. Ther. 298 (2001) 865-872
32. 2-adrenoceptor agonists in acute pain models in mice. Br. J. Pharmacol. 144 (2005) 875-884
33. Warner T.D., and Mitchell J.A. Cyclooxygenases, new forms, new inhibitors, and lessons from the clinic. FASEB J. 18 (2004) 790-804
34. Yoon M.H., Choy J.I., Kim S.J., Kim C.M., Bae H.B., and Chung S.T. Synergistic antinociception between zaprinast and morphine in the spinal cord of rats on the formalin test. Eur. J. Anaesthesiol. 23 (2006) 65-70